Untapped Ophthalmology Target eye care providers, ophthalmology researchers, and retinal clinics with AAGP demonstrations focused on macular degeneration and dry eye disease to position ProtoKinetix as a novel regenerative option.

Transplant Support Engage transplant centers and immunology departments to explore AAGP as a cell-survival and graft-protection enhancer, highlighting potential to improve transplant outcomes and reduce rejection.

Dermatology Synergy Approach dermatology clinics and cosmetic biotech partners about anti-aging and tissue regeneration applications, emphasizing longer-lasting cell viability and potential market for regenerative skin therapies.

Cardio & Metabolic Coordinate with academic medical centers and biotech investors focusing on cardiometabolic disorders to discuss PKTX’s PKX-001 platform and its potential to address inflammation-related conditions.

Strategic Partnerships Propose co-development or research collaborations with larger biotechs or contract research organizations to leverage PKTX’s patented AAGP and accelerate clinical pathways, licensing, or manufacturing partnerships.